Cite
TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment
MLA
Xianjiang Kang, et al. “TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.” International Journal of Molecular Sciences, vol. 22, no. 10930, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c398fcc1475577e1e8a1b74522bfabe2&authtype=sso&custid=ns315887.
APA
Xianjiang Kang, Hailong An, Xue Bai, Shuai Guo, Yawen Deng, & Sai Shi. (2021). TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. International Journal of Molecular Sciences, 22(10930).
Chicago
Xianjiang Kang, Hailong An, Xue Bai, Shuai Guo, Yawen Deng, and Sai Shi. 2021. “TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.” International Journal of Molecular Sciences 22 (10930). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c398fcc1475577e1e8a1b74522bfabe2&authtype=sso&custid=ns315887.